Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.31 +0.10 (+1.16%)
At close: Sep 29, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Convertible Debt (2022 - 2024)

Updated

Eupraxia Pharmaceuticals (EPRX) reported Convertible Debt of -$355,582 for the quarter ended Dec 31, 2024, compared with $10.34 million a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Convertible Debt (2022 - 2024) Analysis & Trends

Dating back to the quarter ended Dec 31, 2022, Eupraxia Pharmaceuticals' Convertible Debt record includes 5 quarters.

  • By year, Convertible Debt came in at $10.34 million in the year ended Dec 31, 2023 (+18.2%) and $8.74 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Eupraxia Pharmaceuticals 328.04 Mn 326.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -355,582.00
Jun 30, 2024 4.53 Mn
Mar 31, 2024 9.48 Mn
Dec 31, 2023 10.34 Mn
Dec 31, 2022 8.74 Mn
API Access

Eupraxia Pharmaceuticals Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=EPRX&period=max&api_key=YOUR_API_KEY